Home > Financial Ratios > AAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
AAREY DRUGS & PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for AAREY DRUGS & PHARMACEUTICALS
Please provide your vote to see the results

AAREY DRUGS & PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 10.1713.599.298.476.14

What is the latest EV/Core EBITDA ratio of AAREY DRUGS & PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of AAREY DRUGS & PHARMACEUTICALS is 10.17 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar202510.17
Mar202413.59
Mar20239.29
Mar20228.47
Mar20216.14

How is EV/Core EBITDA of AAREY DRUGS & PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 10.17
-25.17
Mar2024 13.59
46.29
Mar2023 9.29
9.68
Mar2022 8.47
37.95
Mar2021 6.14 -

Other Financial Ratios of AAREY DRUGS & PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of AAREY DRUGS & PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AAREY DRUGS & PHARMACEUTICALS ₹258.4 Cr -0% 20.9% 65.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,075.0 Cr 0.4% 10.8% 10.5% Stock Analytics
DIVIS LABORATORIES ₹179,486.0 Cr 0.7% 9.5% 16.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,124.0 Cr -2.5% 6% 36.2% Stock Analytics
CIPLA ₹115,641.0 Cr 9.7% 16.7% -4.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,589.0 Cr 4.5% 9.7% 9% Stock Analytics


AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AAREY DRUGS & PHARMACEUTICALS

-0%

20.9%

65.8%

SENSEX

-2.7%

-2.1%

-5.3%


You may also like the below Video Courses